Puzzling over MDM4-p53 network

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 7, 2010, Pages 1080-1083

  Mancini, F ^a,b   Di Conza, G ^a,c   Monti, O ^a,b   Macchiarulo, A ^d   Pellicciari, R ^d   Pontecorvi, A ^b   Moretti, F ^a  

^a CNR   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cancer; DNA damage; MDM2; MDM4 (MDMX); P53

Indexed keywords

PROTEIN MDMX; PROTEIN P53; MDM4 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL STRESS; DNA DAMAGE; GROWTH REGULATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; SHORT SURVEY; TRANSCRIPTION REGULATION; UBIQUITINATION; BIOLOGICAL MODEL; CELL PROLIFERATION; CHEMISTRY; METABOLISM; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953545169     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.04.010     Document Type: Short Survey

References (30)

1. Abdel-Fatah T.M., Powe D.G., Agboola J., Adamowicz-Brice M., Blamey R.W., Lopez-Garcia M.A., Green A.R., Reis-Filho J.S., Ellis I.O. The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. J Pathol 2010, 220:419-434.
2. Barboza J.A., Iwakuma T., Terzian T., El-Naggar A.K., Lozano G. Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol Cancer Res 2008, 6:947-954.
3. Chen L., Li C., Pan Y., Chen J. Regulation of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol 2005, 25:6509-6520.
4. Chen L., Gilkes D.M., Pan Y., Lane W.S., Chen J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J 2005, 24:3411-3422.
5. Eischen C.M., Lozano G. p53 and MDM2: antagonists or partners in crime?. Cancer Cell 2009, 15:171-183.
6. Gilkes D.M., Pan Y., Coppola D., Yeatman T., Reuther G.W., Chen J. Regulation of MDMX expression by mitogenic signaling. Mol Cell Biol 2008, 28:1999-2010.
7. Jin Y., Dai M.S., Lu S.Z., Xu Y., Luo Z., Zhao Y., et al. 14-3-3γ binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 2006, 25:1207-1218.
8. Kim S., Aladjem M.I., McFadden G.B., Kohn K.W. Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage. PLoS Comput Biol 2010, 6:e1000665.
9. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
10. Lopez-Pajares V., Kim M.M., Yuan Z.M. Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding. J Biol Chem 2008, 283:13707-13713.
11. Mancini F., Di Conza G., Pellegrino M., Rinaldo C., Prodosmo A., Giglio S., et al. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J 2009, 28:1926-1939.
12. Mancini F., Moretti F. Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle 2009, 8:3854-3859.
13. Marine J.-C., Dyer M.A., Jochemsen A.G. MDMX: from bench to bedside. J Cell Sci 2007, 120:371-378.
14. Marine J.-C., Francoz S., Maetens M., Wahl G., Toledo F., Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 2006, 13:927-934.
15. Nanni S., Priolo C., Grasselli A., D'Eletto M., Merola R., Moretti F., et al. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Mol Cancer Res 2006, 4:79-92.
16. Okamoto K., Kashima K., Pereg Y., Ishida M., Yamazaki S., Nota A., et al. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol 2005, 25:9608-9620.
17. Pereg Y., Shkedy D., de Graaf P., Meulmeester E., Edelson-Averbukh M., Salek M., et al. Phosphorylation of Hdmx mediates its Hdm2 and ATM-dependent degradation in response to DNA damage. PNAS 2005, 102:5056-5061.
18. Pereg Y., Lam S., Teunisse A., Biton S., Meulmeester E., Mittelman L., et al. Differential roles of ATM and Chk2-mediated phosphorylations of HDMX in response to DNA damage. Mol Cell Biol 2006, 26:6819-6831.
19. Popowicz G.M., Czarna A., Holak T.A. Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain. Cell Cycle 2008, 7:2441-2443.
20. Prodosmo A., Giglio S., Moretti S., Mancini F., Barbi F., Avenia N., et al. Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. J. Mol Med 2008, 86:585-596.
21. Shmueli A., Oren M. Mdm2: p53's lifesaver?. Mol Cell 2007, 25:794-796.
22. Shvarts A., Steegenga W.T., Riteco N., van Laar T., Dekker P., Bazuine M., et al. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 1996, 15:5349-5357.
23. Tang Y., Zhao W., Chen Y., Zhao Y., Gu W. Acetylation is indispensable for p53 activation. Cell 2008, 133:612-626.
24. Thompson A.M., Lane D.P. P53 transcriptional pathways in breast cancer: the good, the bad and the complex. J Pathol 2010, 220:401-403.
25. Tsvetkov P., Reuven N., Prives C., Shaul Y. The susceptibility of the p53 unstructured N-terminus to 20S proteasomal degradation programs stress response. J Biol Chem 2009, 284:26234-26242.
26. Wade M., Wahl G.M. Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?. Mol Cancer Res 2009, 7:1-11.
27. Wang Y.V., Leblanc M., Wade M., Jochemsen A.G., Wahl G.M. Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated Kinases. Cancer Cell 2009, 16:33-43.
28. Wang Y.V., Wade M., Wahl G.M. Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo. Cell Cycle 2009, 8:3443-3444.
29. Zhu Y., Poyurovsky M.V., Li Y., Biderman L., Stahl J., Jacq X., et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 2009, 35:316-326.
30. Zuckerman V., Lenos K., Popowicz G.M., Silberman I., Grossman T., Marine J.-C., et al. c-Abl phosphorylates Hdmx and regulates its interaction with p53. J Biol Chem 2009, 284:4031-4039.